Mutations in the SCN5A gene, encoding the cardiac voltage-gated sodium channel Na V 1.5, are associated with inherited cardiac arrhythmia and conduction disease. Ca 2+ -dependent mechanisms and the involvement of β-subunit (Na V β) in Na V 1.5 regulation are not fully understood. A patient with severe sinus-bradycardia and cardiac conduction-disease was genetically evaluated and compound heterozygosity in the SCN5A gene was found. Mutations were identified in the cytoplasmic DIII-IV linker (K1493del) and the C-terminus (A1924T) of Na V 1.5, both are putative CaM-binding domains. These mutants were functionally studied in human embryonic kidney (HEK) cells and HL-1 cells using whole-cell patch clamp technique. Calmodulin (CaM) interaction and cell-surface expression of heterologously expressed Na V 1.5 mutants were studied by pull-down and biotinylation assays. The mutation K1493del rendered Na V 1.5 non-conductive. Na V 1.5 K1493del altered the gating properties of co-expressed functional Na V 1.5, in a Ca 2+ and Na V β1-dependent manner. Na V 1.5 A1924T impaired Na V β1-dependent gating regulation. Ca 2+ -dependent CaM-interaction with Na V 1.5 was blunted in Na V 1.5 K1493del . Electrical charge substitution at position 1493 did not affect CaM-interaction and channel functionality. Arrhythmia and conduction-disease -associated mutations revealed Ca 2+ -dependent gating regulation of Na V 1.5 channels. Our results highlight the role of Na V 1.5 DIII-IV linker in the CaM-binding complex and channel function, and suggest that the Ca 2+ -sensing machinery of Na V 1.5 involves Na V β1.
INTRODUCTION
Sodium current (I Na ) upstroke is a hallmark of the action-potential in excitable cells. The SCN5A gene encodes the pore-forming α-subunit of the cardiac sodium channel Na V 1.5. Na V 1.5 channels are expressed in cardiomyocytes as well as the cardiac His-Purkinje system. Accordingly, Na V 1.5 loss-of-function mutations are associated with cardiac arrhythmia and conduction defects (Schott et al., 1999; Tan et al., 2001; Holst et al., 2010; Zumhagen et al., 2013) . Although I Na does not contribute to the action potential of pacemaker cells, its presence in the periphery of the sinoatrial node can modulate impulse conduction and heart rate (Kodama et al., 1997) . Hence, loss-of-function mutations in SCN5A can result in a nodal dysfunction (Benson et al., 2003; Lei et al., 2008; Gui et al., 2010; Ziyadeh-Isleem et al., 2014; Chiang et al., 2015; Milanesi et al., 2015) .
The Na V 1.5 α-subunit is composed of four homologous domains (DI-DIV), each containing six transmembrane repeats. The domains are joined by three cytosolic linkers and flanked by cytosolic C-and N-termini (see Figure 1C) . The α-subunit forms a functional monomer; however, multi-channel assembly and functional coupling among monomeric channels have been reported (Keller et al., 2005; Poelzing et al., 2006; Clatot et al., 2017) . Moreover, the α-subunit is the core of a macromolecular complex that interacts with auxiliary proteins that modulate expression, trafficking, localization and gating of Na V 1.5; among them the regulatory β-subunits (Na V β) and the Ca 2+ -sensor calmodulin (CaM) (Abriel, 2010) . Na V 1.5 is regulated by Ca 2+ , but the role and mechanism of this regulation is still debated BenJohny et al., 2014; Gabelli et al., 2016; Pitt and Lee, 2016; Johnson, 2019) . CaM interacts with Na V 1.5 C-terminus (CT) (Gabelli et al., 2014; Wang et al., 2014) , and the linker between domains DIII-IV (DIII-IV linker) (Sarhan et al., 2012; Johnson et al., 2018) . However, the contribution of each CaM-interaction domain to the Ca 2+ -sensing machinery of Na V 1.5 is not fully established. Na V β1 interacts non-covalently with Na V 1.5 and can modulate I Na gating, as well as transcription and cell-adhesion (Calhoun and Isom, 2014) . The involvement of Na V β1 in Ca 2+ -dependent gating regulation is not clear.
We report a novel combination of SCN5A variants, K1493del and A1924T, in a patient with sinus-bradycardia and cardiac conduction-disease. Heterozygous A1924T has been previously associated with Brugada syndrome (BrS) (Rook et al., 1999) , and homozygous A1924T with sinus-bradycardia with conduction delay (Lopez et al., 2011) . Heterozygous K1493del has been associated with isolated conduction disease (Zumhagen et al., 2013) . Here, we studied the molecular basis of Ca 2+ -and CaM-dependent Na V 1.5 modulation, using the disease-associated mutations.
MATERIALS AND METHODS

Clinical
The proband and his parents gave written informed consents for both the clinical and genetic studies, which were approved by the Institutional Ethics-Committee of the Sheba Medical Center, Tel-Hashomer (approval 2853/03). Evaluation included resting electrocardiogram (ECG), 24-h Holter monitoring (DELMAR
Molecular Biology
A DNA construct of the paternal Na V 1.5 variant was prepared with two variants, A1924T and V1251M, on the same DNA construct and denoted as Na V 1.5 A1924T * . In the maternal channel, Na V 1.5 K1493del , one lysine of the doublet in positions 1492-3 was deleted. N-terminally tagged green-fluorescent protein (GFP)-Na V 1.5 was used (Zimmer et al., 2002) . In the constructs K1493A/E/R the second lysine of the lysine-doublet was substituted with the amino-acids indicated. Point-mutations were prepared by site-directed mutagenesis using a standard PCR (Roche, IN, United States), and followed by sequencing of the entire coding sequence. Rat and human -Na V β1 (rNa V β1 and hNa V β1, respectively) were cloned into pcDNA3 vector using HindIII and EcoRI sites, and followed by an internal ribosome entry site (IRES) and the red fluorescent-protein (RFP) sequence between EcoRI and NotI sites (rNa V β1/RFP and hNa V β1/RFP, respectively). Na V 1.5 (NM_198056.2), calmodulin (M19312), rNa V β1 (M91808) hNa V β1 (NP_001028), and GFP were all in a pcDNA3 vector.
Cell Culture
HEK293 cells were maintained in Dulbecco's Modified Eagle's Medium supplemented with 10% Fetal Bovine Serum, 100 U/ml penicillin, 10 mg/ml streptomycin and 2 mM L-Glutamine (Biological Industries, Kibbutz Beit-Haemek, Israel) at 37 • C with 5% CO 2 . For electrophysiological experiments, transfections were performed in 35 mm dish using Trans-ITx2 (Mirus, Madison, WI, United States) according to the manufacturer's instructions. 1 µg of each construct was used for transfection (Na V 1.5, Na V β1/RFP, and CaM), except in Figure 2A , where 3 µg of GFP tagged-K1493del mutated -Na V 1.5 (GFP-Na V 1.5 K1493del ) and Na V β1/RFP (µg DNA ratio 1:1) were used. When indicated, 0.5 µg GFP was added as a transfection marker. On the following day, cells were plated on coverslips. For biochemical experiments, cells in 10-cm dishes were transfected using the Calcium-Phosphate method. 5-15 µg DNA of Na V 1.5 α-subunit were used, rNa V β1 was added in a 0.6 β:α molar ratio unless otherwise indicated. In Figure 5B , CaM was added in a 2 CaM:α molar ratio. Experiments were performed 48-72 h after transfection.
HL-1 cells were plated in gelatin/fibronectin-coated dishes, in Claycomb media supplemented with 10% Fetal Bovine Serum, 100 µM norepinephrine (Sigma, St. Louis, Mo, United States), 100 U/ml penicillin, 10 mg/ml streptomycin and 2 mM L-Glutamine (Biological Industries). Transfections using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, United States) were performed in 35 mm dishes. On the following day, cells were plated on gelatin/fibronectin-coated coverslips. Experiments were performed 48 h after transfection. 
RNA Extraction and Quantitative PCR
Total RNA was extracted using RNeasy Plus mini kit (Qiagen, Hilden, Germany). Reverse transcription with random primers was performed using the high capacity cDNA reverse transcription kit (Applied Biosystems, CA, United States). cDNA was amplified using KAPA HiFi HotStart ReadyMix (Roche). Quantitative real-time PCR was performed using ABI Step-one plus sequence detection system (Applied Biosystems) with Fast SYBR Green Master Mix reagent (Applied Biosystems). The primers for mouse genes used were, for Na V β1 (NM_011322.2): SCN1B Fw (CGAGGCTGTGTATGGGATGAC)/SCN1B Rv (CCCTCAAAGCGCTCATCTTC), for Na V β2 (NM_001014761.2): SCN2B Fw (GTGAACCACAAGCAGT TCTCT)/SCN2B Rv (TGACACGTCGTACTTACTGGG), for Na V β3 (NM_001286614.1): SCN3B Fw (TGTAATGTG TCCAGGGAGTTTG)/SCN3B Rv (TTCGGCCTTAGAGACCT TTCTG) and for Na V β4 (NM_001013390.3): SCN4B Fw (GGAACCGAGGCAATACTCAGG)/SCN4B Rv (CCGTTAA TAGCGTAGATGGTGGT). Gene expression was quantified using the 2ˆ− Ct method by normalization to the housekeeping gene GAPDH (Fw: TCGTCCCGTAG ACAAAATGG/Rv: TTGAGGTCAATGAAGGGGTC).
Electrophysiology
Currents were recorded using the whole-cell configuration of the patch-clamp technique at 23 • C. Red-and/or green-fluorescent cells were selected for recording. Signals were amplified using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Foster City, CA, United States), sampled at 100 kHz and filtered with a low-pass Bessel filter at 10 kHz. Data was acquired with DigiData1440A and analyzed using pCLAMP 10 software (Axon Instruments). Patch pipettes (Harvard apparatus) resistance was 1.5-4 M . Cells with access resistance over 5 M were discarded. Series resistance was compensated by 85%. Leak currents were subtracted using a P/3 protocol. External solution contained (in mM) 137 NaCl, 4 KCl, 10 Hepes, 10 Glucose, 1.8 CaCl 2 , and 1 MgCl 2 titrated with NaOH to pH 7.4, and adjusted to 310 mOsm. Internal solution contained (in mM) 100 CsF, 25 NaF, 10 Hepes, 10 NaCl, 2 Mg 2+ -ATP and 10 ethylene glycol-bis (β-aminoethyl ether)-N,N,N ,N -tetraacetic acid (EGTA), titrated with CsOH to pH 7.2 and adjusted to 295 mOsm, this pipette solution is (10 mM EGTA) in . For fast Ca 2+ chelation, EGTA was replaced with 10 mM 1,2-BIS (2-AMINOPHENOXY)-ETHANE-N,N,N N -TETRAACETIC ACID [(10 mM BAPTA) Activation protocol was initiated after 2 min, steady-state inactivation (SSI) protocol after 3.25 min and recovery from inactivation after 8 min from the rupture of the cell membrane.
Holding potential was −120 mV. Current-densities were obtained by dividing the peak current by the cell FIGURE 2 | Whole-cell I Na of WT and mutant Na V 1.5 in HEK and HL-1 cells. (A) Top, representative currents elicited from resting potential by depolarizing steps (-70 until -20 mV in 5 mV interval) in HEK cells. Bottom, voltage-dependent amplitudes and maximal current densities, in cells expressing GFP-Na V 1.5 WT , GFP-Na V 1.5 K1493del , and Na V 1.5 K1493del , with and without r/hNa V β1 co-expressing RFP in the same vector. All groups were compared to GFP-WT for statistical significance. (B) WT and mutant Na V 1.5 expressed in HEK cells (without Na V β subunit). Current densities were normalized to the mean current density of Na V 1.5 WT in the same experiment and summarized from 9 experiments. Currents in A and the representative currents in B were recorded in [10 mM EGTA] in . (Ca), Gene expression levels of SCNB1-4 in HL-1 cells. Top, gene levels were quantified by real-time PCR and normalized to GAPDH. Bottom, semi-quantitative PCR. (b), I Na measured in naïve and transfected HL-1 cells, in [10 mM EGTA] in . Mean current densities and representative cells are shown. Statistical significance was determined by one-way ANOVA, followed by Holm-Sidak test. ns, not significant.
capacitance. Normalized current-densities were calculated by dividing the current density of each cell with the mean Na V 1.5 WT current density measured on the same day of the experiment, using the same pipette solution composition. The voltage-dependent activation was calculated by fitting currents, generated by steps from −80 to 40 mV in 5 mV increments for 20 ms, with a modified Boltzmann equation:
, where I is the peak current for the test potential V, Gmax is maximum conductance, Vrev is the reversal potential, Va is the potential for half-activation or half-availability, and k is the slope factor. The normalized conductance was determined by modified Ohm's law G/Gmax = I/Gmax (V-Vrev).
Steady-state inactivation was assayed by a 20 ms test pulse to −20 mV after a 500 ms pre-pulse to varying voltages (from −140 to −45 mV in 5 mV steps). SSI curves were fitted with Boltzmann
Recovery from inactivation curve was obtained by a 1 s conditioning pulse (I1) to -20 mV followed by a test pulse (I2) to -20 mV after a varying time (1-24 ms, with 1 ms steps) at -120 mV. Fractional recovery was calculated as I2/I1. The time constant (τ) and amplitude (A) of recovery from inactivation were obtained by fitting the data with the function y = A(1−e −t/τ ).
Waveform's current decay was fitted to one -exponent fit using Levenberg-Marquardt algorithm, in the form f(t) = Ae −t/τ +C.
Cell Surface Biotinylation and CaM-Beads Pull-Down
For biotinylation experiments, cells were incubated with 0.5 mg/ml EZ-Link Sulfo-NHS-SS-Biotin (Pierce, Rockford, IL, United States) in phosphate buffer saline (pH 8) containing 1 mM Ca 2+ and 0.5 mM Mg 2+ (PBS-CM), for 30 min at 4 • C. The reaction was terminated by incubation in 50 mM glycine in PBS-CM, for 10 min at 4 • C. Cells were scraped and washed with PBS-CM supplemented with 0.5 mM phenylmethylsulfonyl fluoride (PMSF) at 4 • C. Cells were lysed in TNE buffer (in mM): 20 Tris-HCl pH 8, 150 NaCl, 1 EGTA, and 1% NP40 supplemented with 0.5 PMSF, protease inhibitor mixture (Roche), 25 β-glycerol phosphate and 1 Na 3 VO 4 , for 30 min on ice. A 25 µg sample was taken for input. An equal amount of total protein from each group was incubated with streptavidin-agarose beads (Pierce) for 2 h at 4 • C in a rotating device. Samples were washed with TNE buffer supplemented with 0.5 mM PMSF, and proteins were eluted by incubation with sample buffer and freshly added 100 mM DTT, for 1 h at room temperature, and then for 5 min at 65 • C. Na V 1.5 WT and Na V 1.5 K1493del intensities were compared in groups transfected with an equal amount of DNA. For CaM pull-down experiments, cells were collected in PBS supplemented with 0.5 mM PMSF, and lysed with (in mM) 20 Tris-HCl pH 7.5, 150 NaCl, and 1% Triton x100, supplemented with 0.5 PMSF, protease inhibitor mixture (Roche), 25 β-glycerol phosphate and 1 Na 3 VO 4 , for 30 min on ice. A 25 µg sample was taken for input. CaM agarose beads (A6112, Sigma) were washed with (in mM) 20 Tris-HCl pH 7.5, 150 NaCl added with either 2 CaCl 2 , or 10 EGTA, then were incubated with an equal amount of total protein from each group, supplemented with either 2 CaCl 2 or 10 EGTA, for 2 h at 4 • C in a rotating device. Samples were washed with (in mM) 20 Tris-HCl pH 7.5, 150 NaCl and 1% Triton x100 supplemented with 0.5 PMSF, and proteins were eluted with sample buffer, for 5 min at 65 • C.
Normalized Na V 1.5 intensity was calculated by dividing Na V 1.5 intensity by a normalizer, γ-tubulin for inputs (Na V 1.5-input NORM = Na V 1.5/γ-tubulin) and Na-K ATPase for plasma membrane-bound fraction (Na V 1.5-PM NORM = Na V 1.5/Na-K ATPase). Percent of total expression was calculated by dividing intensities of Na V 1.5-input NORM with a control group from the same experiment. Trafficking was calculated by dividing Na V 1.5-PM NORM by Na V 1.5-input NORM , and presented as % trafficking from the control group in the same experiment. CaM-beads binding level was quantified by dividing bound by input fractions and normalized to control group in the same experiment.
The antibodies that were used are hNa V 1.5 (ASC-013, Alomone, Jerusalem, Israel), Na-K ATPase (ANP-001, Alomone), γ-tubulin (T5192, Sigma), and CaM (05-173, Millipore Corp., Temecula, CA, United States).
Presentation and Statistical Analysis
Densitometry of Western blot bands was analyzed using ImageJ (NIH, United States). Figures were prepared using CorelDrawX8 (Corel Corp., Ottawa, Canada). Statistical analyses were performed using SigmaPlot 13 (Systat Software, CA, United States). Data are presented as mean ± SEM. One-way ANOVA followed by the multiple comparison Holm-Sidak post hoc test was used to compare several groups. Two-tailed Student's t-test was used to compare two groups.
RESULTS
Clinical and Genetic Data
A 16-year-old male presented with a syncope during exercise. Physical examination revealed a healthy looking young man without any abnormalities. He had bradycardia for many years but was not previously symptomatic. A 24-h Holter recording showed an average heart rate of 50 (range: 24-110) due to sinus-bradycardia and occasional junctional rhythm with sinus-pauses up to 5.8 s ( Figure 1A , left). A wide complex tachycardia (WCT) of 193 beat-per-minute was recorded during exercise testing ( Figure 1A , right). Echocardiography and cardiac-MRI did not reveal any structural abnormalities or areas of late gadolinium enhancement. Ajmaline provocation test ruled out BrS. Electrophysiological-study demonstrated a prolonged A-H interval of 260 ms and H-V interval of 75 ms. During rapid pacing (420 CL), the H-V interval increased to over 100 ms. Atrial-flutter was inducible with 1:1 conduction, leading to "clinical" WCT. The proband developed symptomatic bradycardia and a permanent pacemaker was eventually implanted.
DNA screening of the proband revealed compound heterozygosity in the SCN5A gene. The paternal allele had two missense variants, leading to amino-acid substitutions of alanine by threonine in position 1924 (A1924T) and valine by methionine in position 1251 (V1251M). The variant V1251M is a benign polymorphism (Kapplinger et al., 2015) . The maternal allele had an in-frame, single codon deletion, resulting in a removal of one out of two adjacent lysines, in positions 1492-1493 (K1493del) (Figures 1B,C) . We cannot rule out the presence of mutation(s) in additional gene(s) that were not identified in the present gene screen.
Holter-testing of both parents did not reveal bradycardia, but the father displayed premature ventricular contractions (PVCs) with Right Bundle Branch Block (RBBB) pattern in V1 on 12-lead ECG. One brother did not have bradycardia. Another brother had bradycardia but he declined any clinical or genetic evaluation ( Figure 1D) .
Although K1493del and A1924T heterozygotes were previously reported with bradyarrhythmias (Rook et al., 1999; Zumhagen et al., 2013) , the heterozygotes in this report were asymptomatic, probably due to reduced disease penetrance in these individuals. The extent and reasons for SCN5A mutation expression variability are not entirely clear. Reasons for the variability may include epigenetic gene silencing, age, gender, environmental factors and other genetic modifiers (Liu et al., 2016; Verkerk et al., 2018) . We suggest that the accumulated effects in the compound-heterozygote may have increased the penetrance and severity of the arrhythmic phenotype compared with the heterozygotes in the reported family.
Complete Loss of Na V 1.5 Activity Due to K1493del Mutation, Without a Dominant-Negative Effect on Current Density
To examine the functional consequences of the variants, we expressed Na V 1.5, WT and mutants, in HEK cells and measured whole-cell I Na . We used N-terminally GFP-fused Na V 1.5 that conserves the biophysical properties of Na V 1.5 (Clatot et al., 2012; Reinhard et al., 2013) . Peak I Na recorded in cells transfected with GFP-Na V 1.5 WT , with or without Na V β1, was 1-6 nA. No I Na was recorded in cells expressing GFP-Na V 1.5 K1493del or the non-tagged Na V 1.5 K1493del . Addition of a bicistronic vector expressing Na V β1 from two species (rat or human) together with RFP as an expression reporter did not recover I Na (Figure 2A) , even when the amount of DNA used for transfection of GFP-Na V 1.5 K1493del +Na V β1 was three-fold higher than GFP-Na V 1.5 WT . These results are at odds with a previous report (Zumhagen et al., 2013) .
Compared with Na V 1.5 WT , the paternal variation Na V 1.5 A1924T * did not affect I Na density. In order to test whether Na V 1.5 K1493del has a dominant-negative effect, GFPNa V 1.5 K1493del was added on top of Na V 1.5 WT or Na V 1.5 A1924T * , in 1:1 DNA ratio. Co-expression of GFP-Na V 1.5 K1493del did not reduce I Na density, in HEK cells ( Figure 2B and Table 1) .
We used HL-1 cells, a mouse atrial cardiomyocyte tumor cell-line (Claycomb et al., 1998) , to test the effect of Na V 1.5 K1493del on endogenous cardiac-cell I Na . HL-1 cells express sodium channel subunits, predominantly the Na V 1.5 α-subunit (Cerrone et al., 2014) and Na V β1 subunit (Figure 2Ca) , that recapitulate the physiological Na V 1.5 stoichiometry in a cardiac cell milieu. We transfected HL-1 cells with GFP-Na V 1.5 WT or GFP-Na V 1.5 K1493del . Naïve, non-transfected, HL-1 cells showed I Na of -144 ± 29 pA/pF. HL-1 cells transfected with GFP-Na V 1.5 WT had I Na of −594 ± 84 pA/pF, while cells transfected with GFP-Na V 1.5 K1493del had a basal I Na of −140 ± 32 pA/pF, similar to non-transfected cells.
These findings demonstrate, in HEK and HL-1 cells, that Na V 1.5 K1493del is a loss-of-function mutant that does not induce a functional dominant-negative effect on I Na density.
K1493del Attenuates Na V 1.5 Expression but Does Not Affect Trafficking
In order to understand if the basis for the loss-of-function in Na V 1.5 K1493del was an impairment in the protein expression or trafficking to the plasma membrane, we performed a biotinylation assay. Na V 1.5 WT and Na V 1.5 K1493del were transfected in HEK cells. Total and plasma-membrane biotin-bound Na V 1.5 protein levels were quantified following Western-blot. We found a reduction in total cellular expression of Na V 1.5 K1493del (40 ± 7% of Na V 1.5 WT ). The % trafficking was determined by dividing the biotinylated fraction by total fraction, normalized to % trafficking of Na V 1.5 WT , in the same experiment. The % trafficking of Na V 1.5 K1493del was not significantly different from % trafficking of Na V 1.5 WT (93 ± 16%) so that a similar fraction from Na V 1.5 total protein was present at the plasma membrane ( Figures 3A,C) , suggesting that trafficking of Na V 1.5 K1493del to the plasma membrane was not impaired. Figure 2B .
WT + GFP (n = 55) −235 ± 22 GFP-WT (n = 14)
−220 ± 24 A1924T * + GFP (n = 39) −247 ± 24 A1924T * + GFP-K1493del (n = 38) −211 ± 18 WT + GFP-K1493del (n = 24) −160 ± 16 FIGURE 3 | Cell surface and total expression of Na V 1.5 WT and Na V 1.5 K1493del . (A,B) Representative biotinylation assays. (A) HEK cells were transfected with Na V 1.5 WT and Na V 1.5 K1493del . The control "no-biotin" group shows no signal from non-biotinylated channels. (B) HEK cells transfected with Na V 1.5 WT and Na V 1.5 K1493del (7.5 µg) +/-rNa V β1 (2.5 and 7.5 µg).
(C) Summary of % total protein (left) and % trafficking (right), normalized to Na V 1.5 WT without Na V β1. N = 9 experiments without Na V β. N = 4 experiments with rNa V β1 expressed. Groups expressing rNa V β1 in molar ratios β:α 0.6-2 were pulled together. (D) GFP-fused and non-tagged Na V 1.5 WT and Na V 1.5 K1493del were expressed (without Na V β subunit). This is a summary of three experiments. Statistical significance was determined by one-way ANOVA, followed by Holm-Sidak test.
Na V β1 has been reported to improve the expression and trafficking of loss-of-function mutants of the sodium channel (Bechi et al., 2015) . We examined the effect of Na V β1 co-expression on total and cell-surface expression of Na V 1.5 WT and Na V 1.5 K1493del . Addition of Na V β1 enhanced total expression of both Na V 1.5 WT and Na V 1.5 K1493del , with a concomitant increase in channel expression at the cell surface ( Figure 3B) . A summary of total and biotinylated Na V 1.5 levels, normalized to the Na V 1.5 WT expressed without Na V β1 in the same experiment, is presented in Figure 3C . Co-expression of Na V β1 increased total expression of Na V 1.5 WT by 215 ± 18% and Na V 1.5 K1493del by ∼400%, increasing the latter from 40 ± 7% to 160 ± 39% (compared to Na V 1.5 WT without Na V β1). Na V 1.5 K1493del trafficking to the plasma membrane was similar to Na V 1.5 WT when Na V β1 was co-expressed. These results support the conclusion that K1493del does not affect forward-trafficking or Na V β1-regulated trafficking and expression ( Figure 3A) .
To test whether the addition of a GFP-tag to Na V 1.5 N-terminus affected the expression or trafficking of Na V 1.5, we performed a biotinylation experiment on GFP-tagged and non-tagged channels. GFP-fusion did not change the biogenesis properties: total expression of GFP-Na V 1.5 K1493del was partially reduced compared to GFP-Na V 1.5 WT , and GFP-tagged Na V 1.5 channels were exported to the plasma membrane ( Figure 3D) .
In summary, K1493del partially reduced total protein expression but did not affect the plasma-membrane trafficking of Na V 1.5. Co-expression of Na V β1 restored the reduced Na V 1.5 K1493del cellular levels but did not restore I Na (Figure 2A) , thus the loss-of-function by K1493del mutation is only marginally due to a biogenesis defect.
Expression of Non-conducting Na V 1.5 K1493del and Na V β1 Affects Ca 2+ -Dependent Gating
We wanted to examine whether the non-conducting channel Na V 1.5 K1493del affects the current of the co-expressed Na V 1.5 A1924T * variant, consistent with the compound heterozygosity observed in the patient. We tested Ca 2+ -dependent gating properties of I Na in view of previous studies that included K1493 and A1924 residues in structural elements that bind the Ca 2+ -sensor CaM: DIII-IV linker and the CT, respectively. When the I Na conducting variants Na V 1.5 A1924T * or Na V 1.5 WT were co-expressed with the non-conducting variant Na V 1.5 K1493del , the latter was expressed as a GFP-fused channel to attest its co-expression in cells that displayed I Na . Co-expression of GFP-Na V 1.5 K1493del resulted in a 3 mV depolarizing shift of the activation curve of Na V 1.5 A1924T * in the presence of [10 µM Ca 2+ ] in but not in the absence of [Ca 2+ ] in . Co-expression of GFP-Na V 1.5 K1493del with Na V 1.5 WT resulted in a similar 3.5 mV depolarizing shift of the activation curve, only in [10 µM Ca 2+ ] in ( Figure 4A and Table 2 ). Although modest, the depolarizing shift in the activation curve in the presence of Ca 2+ was significant. The similar current amplitudes (Table 2 ) and the similar effect in the two unrelated groups argue against the possibility of a recording artifact being the reason for the observed shift.
As previously reported with Na V 1.5 A1924T (Potet et al., 2009 ), the SSI curve of Na V 1.5 A1924T * shifts to hyperpolarized voltages compared to Na V 1.5 WT , in the absence, but not in the presence, of [Ca 2+ ] in . Co-expression of GFP-Na V 1.5 K1493del caused a depolarizing shift of SSI of Na V 1.5 WT and Na V 1.5 A1924T * by 5.6 and 6.4 mV, respectively, in the absence of [Ca 2+ ] in , but did not affect SSI properties in the presence of [10 µM Ca 2+ ] in (Figure 4B and Table 2 ). Recovery from inactivation induced by a 1 s depolarizing pulse was not affected by GFP-Na V 1.5 K1493del co-expression ( Figure 4C and Table 2 ).
To conclude, expression of non-conductive GFPNa V 1.5 K1493del altered the gating properties of co-expressed conducting channels, in a Ca 2+ -dependent manner: a slight decrease in the voltage dependency of activation curve in [10 µM Ca 2+ ] in , and an increase in Na V 1.5 availability following inactivation, in the absence of [Ca 2+ ] in .
Since Na V 1.5 K1493del plasma membrane expression was ∼40% of Na V 1.5 WT , and Na V β1 enhanced Na V 1.5 K1493del membrane expression (Figure 3C) , we decided to examine the Ca 2+ -dependent gating effects of functional channels (Na V 1.5 WT or Na V 1.5 A1924T * ) co-expressed with Na V β1/RFP and GFP-Na V 1.5 K1493del .
Na V β1 expression induced a Ca 2+ -independent depolarizing shift in Na V 1.5 WT SSI (Wingo et al., 2004) , nevertheless, we observed a Ca 2+ -dependent regulation of the activation. Na V β1-expression induced a depolarizing shift in Na V 1. Figure 4D ). A1924T * mutation eliminated Na V β1-dependent effects on gating. Co-expression of Na V β1 did not shift the activation or SSI curves of Na V 1.5 A1924T * , in either the absence or presence of [Ca 2+ ] in (Figures 4D,E and Table 2 ). The same effect was observed when 10 µM Ca 2+ were chelated with HEDTA instead of BAPTA ( Figure 4E) .
Co-expression of GFP-Na V 1.5 K1493del had no significant effect on activation or SSI curves of Na V 1.5 WT +Na V β1, in either the absence or presence of [Ca 2+ ] in . Nevertheless, GFP-Na V 1.5 K1493del co-expression right-shifted the SSI curve of Na V 1.5 A1924T * + Na V β1, only in the absence of [Ca 2+ ] in ( Figure 4F and Table 2 ), similar to the effect recorded without Na V β1 (Figure 4B) . GFP-Na V 1.5 K1493del co-expression did not significantly change the activation properties of Na V 1.5 A1924T * + Na V β1 (Table 2) . Thus, the mutation A1924T * blunted Na V β1-induced gating regulation and partially restored the effects that were induced by GFP-Na V 1.5 K1493del co-expression.
We suggest that Na V β1 directly affects Na V 1.5 Ca 2+ -dependent gating in addition to its role in expression regulation. Our results demonstrate, for the first time, that Na V β1-regulates Na V 1.5 gating in a Ca 2+ -dependent manner, and that Na V β1-induced regulation mechanism includes the A1924 residue. In summary, Na V 1.5 Ca 2+ -sensitivity involves multiple elements, including both CaM-interacting elements: CT and DIII-IV, and possibly a protein complex that includes more than one Na V 1.5 channel.
K1493del Mutation Modulates
CaM-Na V 1.5 Interaction
We wanted to examine CaM-interaction with Na V 1.5 variants, since CaM directly interacts with Na V 1.5 at the two domains where variants were found in the proband: A1924T located in the conserved IQ-domain in the cytoplasmic CT (Gabelli et al., 2014; Wang et al., 2014) , and K1493del in the proximal segment of the cytoplasmic DIII-IV linker (Potet et al., 2009; Sarhan et al., 2012; Johnson et al., 2018 ; Figure 1C) . We explored the interactions of The test-pulse trace that follows -80 mV pre-pulse is red. (C) Recovery from inactivation. (D) Activation (top) and SSI (bottom) curves of Na V 1.5 WT +GFP and Na V 1.5 A1924T * +GFP co-expressing rNa V β1/RFP were plotted with the fitted curves of these groups without rNa V β1/RFP (presented in A, B). Current traces recorded in [10 µM Ca 2+ ] in . The -40 mV trace during activation and the test-pulse that follows the -80 mV pre-pulse during SSI are red. (E) Activation (left) and SSI (right) curves with 10 µM Ca 2+ chelated with HEDTA in the internal solution. (F) Activation (left) and SSI (right) curves of Na V 1.5 variants co-expressing rNa V β1/RFP and GFP-Na V 1.5 K1493del were plotted with the fitted curves of these groups without GFP-Na V 1.5 K1493del (presented in D). Statistical significance of Va was determined by t-test: ns, not significant; * p < 0.05; * * p < 0.01; * * * , p < 0.001 (see Table 2 ).
CaM with Na V 1.5 expressed in HEK cells by a pull-down essay using CaM-coated agarose beads.
CaM interaction in the presence of 2 mM Ca 2+ (Ca 2+ /CaM interaction) and in the absence of Ca 2+ (apo-CaM interaction in 10 mM EGTA) with Na V 1.5 WT and mutants in the same experiment, were normalized to Ca 2+ /CaM-Na V 1.5 WT interaction. Co-expression of Na V β1 enabled comparable protein expression levels of Na V 1.5 K1493del and Na V 1.5 WT . A three-fold reduction in CaM-Na V 1.5 WT interaction in the absence of Ca 2+ (from 100% with Ca 2+ to 35 ± 13% without Ca 2+ ), and a two-fold reduction in CaM-Na V 1.5 A1924T * interaction in the absence of Ca 2+ (from 108 ± 8% with Ca 2+ to 51 ± 6% without Ca 2+ ) were observed ( Figure 5A) . Ca 2+ /CaM interaction with Na V 1.5 K1493del were strongly reduced (20 ± 5% of Na V 1.5 WT ). The Ca 2+ /CaM and apo-CaM interaction with Na V 1.5 K1493del were not significantly different, indicating an impaired Ca 2+ -dependent interaction ( Figure 5A) .
CaM co-expression enhanced total-expression of Na V 1.5 WT by 161 ± 18% and Na V 1.5 K1493del by 387 ± 93% (Figures 5Ba,b) , suggesting that despite a reduction in Ca 2+ /CaM interaction, CaM regulates the expression levels of Na V 1.5 K1493del . Upregulation of Na V 1.5 K1493del expression in the presence of over-expressed CaM enabled quantification of CaMNa V 1.5 K1493del interaction. The ratio of Na V 1.5 bound-to-input levels in 2 mM Ca 2+ was lower in Na V 1.5 K1493del compared to Na V 1.5 WT (58 ± 10%, Figures 5Ba,c) . Thus, CaM TABLE 2 | Gating properties of Na V 1.5 in different Ca 2+ chelation. Significance between two groups was tested using a two-tailed t-test, in the same solution unless otherwise mentioned. β subunits were expressed with RFP in the same vector (β1/RFP).
Frontiers in Physiology | www.frontiersin.org FIGURE 5 | CaM-interaction with Na V 1.5 variants (A). HEK cells were transfected with Na V 1.5 WT , Na V 1.5 K1493del , and Na V 1.5 A1924T * together with rNa V β1. Lysates from transfected groups were pulled-down with CaM-agarose beads in Ca 2+ and EGTA. Left, a representative Western blot from a pull-down assay. Right, the CaM-bound fraction was normalized to input level, and presented as % of Na V 1.5 WT in 2 mM Ca 2+ , in the same experiment. Statistical significance was determined by one-way ANOVA followed by Holm-Sidak test. P-value compared to Na V 1.5 WT in 2 mM Ca 2+ is indicated above each bar. (B) Na V 1.5 WT and Na V 1.5 K1493del with or without co-expressed CaM were pulled-down with CaM-agarose beads in 2 mM Ca 2+ . (a) CaM-bound Na V 1.5, and total input levels of Na V 1.5, CaM and γ-tubulin were detected in Western-blot. (b) Input Na V 1.5+CaM levels were normalized to Na V 1.5 without CaM, from the same experiment, N = 4. (c) CaM-bound fractions were normalized to input levels, and are presented as % of Na V 1.5 WT +CaM in the same experiment, N = 3. Statistical significance was estimated by t-test.
(C) HEK cells transfected with equal total Na V 1.5 α-subunit (7.5 µg; ratio 1:1, 3.75 µg of each construct; ratio 1:4, 1.5, and 6 µg of the constructs indicated) together with rNa V β1. Lysates from transfected groups were pulled-down with CaM-agarose beads in 2 mM Ca 2+ . This is a representative experiment out of two.
over-expression was not able to fully restore the reduction in Ca 2+ /CaM-Na V 1.5 K1493del interaction. We wanted to determine whether the combination of the two mutated channels, as presented in the patient, affects the overall binding of the expressed channels to CaM. We hypothesized that a cross-talk between Na V 1.5 proteins would result in cooperative CaM-interaction and that reduced Ca 2+ /CaM-interaction in Na V 1.5 K1493del would interfere with overall Ca 2+ /CaM-interaction. Our results did not support this hypothesis. The extent of overall channel binding to CaM beads in 2 mM Ca 2+ varied proportionally to the ratio of expressed Na V 1.5 K1493del and Na V 1.5 A1924T * : the more Na V 1.5 K1493del -the less overall CaM binding ( Figure 5C ).
The Mechanism of Na V 1.5 K1493del Loss-of-Function
The lysine doublet in position 1492-3 is positively charged and is located in a region rich with polar and charged residues that could potentially contribute to protein-protein interactions ( Figure 6A) . These residues are located in a conserved helical structure, downstream of the IFM motif that confers fast inactivation (West et al., 1992) . We hypothesized that a salt-bridge could affect channel function and CaM interaction. To test this, we created three Na V 1.5 mutants, where the lysine in position 1493 was mutated to the neutral residue alanine, Na V 1.5 K1493A , the negative residue glutamate, Na V 1.5 K1493E , or another positive residue, arginine, Na V 1.5 K1493R .
Analysis of Na V 1.5 currents revealed that all three mutated channels were functional (Figures 6Ba,b) . However, inactivation properties were altered. Using a single-exponential fit to estimate the inactivation time constant, τ, we found that when the positive charge in residue 1493 was conserved (K1493R), inactivation rate was similar to WT, as previously reported (Li et al., 2009 ). However, the inactivation rate was increased when K1493 was changed to an uncharged or a negatively charged residue (K1493A/E, respectively, Figure 6Bc) . These results indicate that the electric charge in position 1493 is important for fast-inactivation kinetic properties, but not for the total function.
Expression analysis showed that the total protein levels of the three mutants Na V 1.5 K1493A/E/R were not significantly The total expression as quantified in EGTA, and normalized to Na V 1.5 WT (N = 3). (c) Pull-down experiments with CaM-agarose beads. The CaM-bound fraction was normalized to input level and quantified as % of Na V 1.5 WT in 2 mM Ca 2+ (N = 3). Statistical significance was determined by one-way ANOVA, followed by Holm-Sidak test, compared to WT in 2 mM Ca 2+ . * * p < 0.01; * p < 0.05. (D) GFP-Na V 1.5 WT (a) or GFP-Na V 1.5 K1493del (b) coexpressed with rNa V β1/RFP and CaM in HEK cells. 2 or 20 mg/ml pronase were added to (10 mM EGTA) in pipette solution. t indicates the time from the beginning of the recording. (a) Currents elicited from -120 mV to -20 mV for 100 ms, every 30 s. Between pulses, the cells were held at -120 mV. Inactivation was evaluated by r 5 , which is the fraction of current that remained after 5 ms at -20 mV (I 5ms /I peak ), n = 5 in each group (left). Representative currents during repetitive steps to -20 mV (middle), and activation protocols in the same cell, at different time points (right). (b) Recording from cells expressing GFP-Na V 1.5 K1493del with 20 mg/ml pronase in the pipette solution. Currents during repetitive depolarization (left) and activation protocols (right) at different time points are presented. This is a representative cell out of 12 cells. different from Na V 1.5 WT (Figures 6Ca,b) . CaM-interaction with Na V 1.5 K1493A/E/R was Ca 2+ -dependent, similar to Na V 1.5 WT (Figures 6Ca,c) . This set of experiments demonstrates that, unlike the robust effect of the K1493 deletion mutation, the biochemical and functional characteristics of Na V 1.5 are not highly dependent on the electric charge in K1493 residue.
We further explored the mechanism of Na V 1.5 K1493del loss-of-function in view of the mutation location, in Na V 1.5 inactivation gate. We hypothesized that Na V 1.5 K1493del is constitutively inactivated resulting in a channel-pore block. To address this hypothesis, we used the protease pronase that selectively destroys the inactivation of sodium channels while leaving activation intact (Armstrong et al., 1973) . HEK cells were transfected with GFP-Na V 1.5 WT or GFP-Na V 1.5 K1493del together with both CaM and Na V β1/RFP to allow maximal expression of Na V 1.5 variants. Dialysis of 20 mg/ml pronase into the cell through the patch pipette gradually relieved the inactivation of Na V 1.5 WT I Na until its complete elimination after 12 min. The effect on I Na inactivation was dose-dependent and 2 mg/ml pronase did not eliminate the inactivation in 12 min (Figure 6Da) . Cells expressing GFP-Na V 1.5 K1493del and Na V β1/RFP in addition to CaM had no I Na . Dialysis of 20 mg/ml pronase, in the same protocol used for Na V 1.5 WT , did not restore Na V 1.5 K1493del current. We conclude that the reasons for Na V 1.5 K1493del loss-of-function are beyond a change in the inactivation properties, and probably involve structural and additional functional perturbations.
DISCUSSION
Sinus-bradycardia and cardiac conduction-disease in the proband were associated with novel heterozygous SCN5A variants composition, K1493del in DIII-IV linker and A1924T * in the CT of Na V 1.5. Deletion of K1493 caused a complete loss of Na V 1.5 function. Surprisingly, the expression of the non-conducting Na V 1.5 K1493del affected Ca 2+ -dependent gating properties of co-expressed conducting channels. Moreover, Ca 2+ -dependent CaM-Na V 1.5 interaction was impaired in Na V 1.5 K1493del . A Ca 2+ -dependent Na V β1 modulation that was characterized in Na V 1.5 WT currents, was impaired in the Na V 1.5 A1924T * variant. These results highlight the significance of Na V 1.5 DIII-IV linker in channel function and CaM-interaction and suggest that the Ca 2+ -sensing machinery of Na V 1.5 involves Na V β1 and more than one monomeric Na V 1.5 channel.
Function and Biogenesis of Na V 1.5 K1493del
Sodium channelopathies usually occur due to disruption of two mechanisms: gating and/or biogenesis, a process that includes synthesis, folding, assembly of the macromolecular complex, trafficking to the plasma membrane and localization in cell surface compartments (Chen-Izu et al., 2015) . Co-expression of the auxiliary proteins Na V β1 and CaM increased Na V 1.5 WT and Na V 1.5 K1493del total expression (Figures 3B, 5Bb) , possibly by serving as chaperons, suggesting a proper biogenesis regulation of Na V 1.5 K1493del by these proteins. The Na V β1 and the ubiquitous CaM are expressed throughout the heart and the cardiac conduction system (O'malley and Isom, 2015) . Thus, we assume that expression levels of Na V 1.5 K1493del in the human heart are close to the physiological levels of Na V 1.5 WT .
The non-conducting channel Na V 1.5 K1493del did not exert a dominant-negative effect on the macroscopic current density of Na V 1.5 WT or Na V 1.5 A1924T * in HEK cells, or on endogenous I Na of HL-1 atrial cells. Hence, Na V 1.5 K1493del does not impair biogenesis of other sodium channels, a mechanism reported in other Na V 1.5 mutants (Keller et al., 2005; Clatot et al., 2012; Hoshi et al., 2014) .
Deletion of K1493 resulted in a loss of I Na . Changing K1493 electrostatic properties did not reduce I Na but only modified inactivation kinetics (Figure 6B) . Based on the location of the mutation in the inactivation gate, a constitutive inactivation state could account for Na V 1.5 K1493del loss-of-function. However, pronase, a protease that relieves the inactivation of sodium channels following the digestion of DIII-IV linker (Stühmer et al., 1989) , did not restore Na V 1.5 K1493del currents ( Figure 6D) . Possible explanations are, first, that K1493del mutation altered Na V 1.5 DIII-IV linker conformation to hinder the access of pronase to its target sequence. In an inactivated state, the IFM motif acts as a latch of a hinged-lid that docks within the pore. If K1493del does not allow a release of the latch in resting potentials, then the channel remains locked in an inactivated state, and the substrate of pronase might not be exposed to the cytoplasm. A second possible explanation is that K1493 deletion not only destabilized the inactivation gate but also lead to a major deformation that obstructed the pore's cytosolic mouth. In this case, a twisted DIII-IV linker conformation results in a global interference in the protein structure and distal interaction with other Na V 1.5 cytosolic elements. Both options imply that the lysines in position 1492-3 are pivotal residues in Na V 1.5 gate and that removal of one lysine alters fundamental functional and structural elements in the channel gate.
Unlike a previous report (Zumhagen et al., 2013) , we were unable to record I Na in HEK cells expressing Na V 1.5 K1493del .
In the previous and the current reports, Na V 1.5 K1493del was expressed in HEK cells, and the patch-clamp solutions and experimental conditions were essentially similar. We tested several mechanisms that may have contributed to the discrepancy: (1) Impaired cellular expression: total and surface expression of Na V 1.5 K1493del was confirmed by Western blot and biotinylation assay (Figure 3) . (2) Low transfection of Na V 1.5 α-subunit: currents were measured in cells expressing GFP-labeled α-subunit (Na V 1.5 WT and Na V 1.5 K1493del ), and the amount of DNA used for transfection of Na V 1.5 K1493del was three-fold higher. (3) Functional variability between Na V β1 species: Na V β1 subunit from two species were used (rat and human; the human Na V β1 was previously used). (4) Low expression of Na V β1 subunit: Na V β1 was co-expressed with a fluorescent marker in a bicistronic vector. (5) Finally, the coding sequences of the constructs were fully sequenced, and two separately constructed α-subunit mutants (Na V 1.5 K1493del and GFP-Na V 1.5 K1493del ) were tested. In summary, our results show that Na V 1.5 K1493del is a loss-of-function mutation due to a gating rather than a biogenesis defect, and the reason for the discrepancy with the previous report could not be determined.
DIII-IV Linker
Mediates Ca 2+ -Dependent Na V 1.5-CaM Interaction
The Ca 2+ -sensing machinery of Na V 1.5 may include the DIII-IV linker, CT and the Ca 2+ sensor CaM. Interaction of CaM with DIII-IV linker was studied mainly using small peptides (Kim et al., 2004; Potet et al., 2009; Sarhan et al., 2012; Yan H. et al., 2017; Johnson et al., 2018) , but the relevance of DIII-IV linker to the overall CaM-binding complex in the full Na V 1.5 protein is unclear. The binding affinities of Na V 1.5-CT peptide to CaM were not Ca 2+ -sensitive (Wang et al., 2014) , while Ca 2+ -dependent enhancement in CaM binding was measured with DIII-IV linker segments (Sarhan et al., 2009; Sarhan et al., 2012; Johnson et al., 2018) . We detected a novel property of CaM interaction with full Na V 1.5 expressed in cells: Ca 2+ /CaM was stronger than apo-CaM interaction, in Na V 1.5 WT and the variants Na V 1.5 A1924T * ( Figure 5A ) and Na V 1.5 K1493A/E/R ( Figure 6C ) when using pull-down assay. K1493del blunted the Ca 2+ -dependent CaM-interaction: Ca 2+ /CaM-Na V 1.5 K1493del interaction was similar to apo-CaM-interaction with Na V 1.5 WT or Na V 1.5 K1493del . These results highlight the role of DIII-IV linker in CaM binding complex, suggesting that the Ca 2+ -dependent CaM-interaction with Na V 1.5 DIII-IV linker contributes, directly or indirectly, to the overall enhancement in Ca 2+ /CaM-Na V 1.5 interaction.
The Na V 1.5 Mutation A1924T Does Not Eliminate Ca 2+ -Dependent CaM-Interaction A1924T mutation reduced Ca 2+ /CaM-interaction in a CT peptide (Wang et al., 2014) . However, the length of Na V 1.5 CaM-interacting segments was shown to be crucial for determining binding affinities to CaM [(Wang et al., 2014; Johnson et al., 2018) vs. (Sarhan et al., 2012) ]. When we pulled-down the full-length expressed Na V 1.5, the interaction between Ca 2+ /CaM and Na V 1.5 A1924T * was not weakened compared to Na V 1.5 WT , unlike the reports in CT segments. However, in the absence of Ca 2+ , Na V 1.5 A1924T * -CaM interaction was slightly higher compared to Na V 1.5 WT , so the "net" Ca 2+ -dependent change in CaM interaction was diminished. Our results point that the binding of CaM to a native Na V 1.5 channel is probably determined by multiple segments, e.g., both the CT and the DIII-IV linker. CaM affinities to separate segments may not reflect the full dynamic interaction. Understanding the mode of integration of all Na V 1.5-CaM binding elements within the complete channel protein is indispensable for resolving the mechanism of CaM-regulation in a physiological context. Pioneering cryogenic electron microscopy (cryo-EM) studies were able to capture the cytosolic complex of sodium channels (Shen et al., 2017; Yan Z. et al., 2017) , and together with functional and molecular information the understanding of the complex and dynamic Ca 2+ -dependent regulation will be refined.
Na V 1.5 Gating Is Ca 2+ -Dependent
Several studies demonstrated that Na V 1.5 is regulated by Ca 2+ (Deschenes et al., 2002; Tan et al., 2002; Kim et al., 2004; Wingo et al., 2004; Biswas et al., 2009; Glynn et al., 2015; Gabelli et al., 2016; Abdelsayed et al., 2017) , but the molecular details and the physiological relevance remains highly controversial [e.g. (Ben-Johny et al., 2014) ]. We showed that Na V 1.5 K1493del is located in the plasma membrane as a non-conducting channel. If individual Na V 1.5 monomers gate independently of others, the "silent" mutant Na V 1.5 K1493del would not have contributed to overall macroscopic current properties when expressed with other channels in the same cell. Strikingly, expression of the non-conducting mutant channel affected the Ca 2+ -dependent gating of macroscopic current arising from co-expressed conducting channels. Co-expression of Na V 1.5 K1493del similarly altered the Ca 2+ -dependent gating properties of both Na V 1.5 WT and Na V 1.5 A1924T * : a depolarization shift in the voltage-dependent activation with [Ca 2+ ] in and SSI-curve in the absence of [Ca 2+ ] in .
Previous studies provided evidence that Na V 1.5 proteins are in physical proximity when expressed in cells (Clatot et al., 2012; Mercier et al., 2012; Clatot et al., 2018) . This interaction is indirect, via 14-3-3 protein (Clatot et al., 2017) . Functional cooperation of the gate has been demonstrated when loss-of-function Na V 1.5 mutant impaired Na V 1.5 WT gating by a dominant-negative mechanism (Clatot et al., 2018) while several other mutations showed a dominant-negative effect via defective biogenesis that suggests co-trafficking of several channels [reviewed in (Sottas and Abriel, 2016) ]. Here, the expression of Na V 1.5 K1493del did not cause a dominant-negative loss-of-function effect (Figures 2B,C) . We propose that the loss of Ca 2+ /CaM-interaction due to K1493del mutation prompted changes in the Ca 2+ -dependent gating of co-expressed conducting channels. Thus, our results support a cooperative gating regulation of multimeric-Na V 1.5 complex and suggest that this mechanism involves a Ca 2+ /CaM-regulated component. To note, CaM plays a critical role in the functional coupling of the structurally homologous calcium channel, Ca V 1.2 (Dixon et al., 2015) . In summary, the mutation K1493del underlines the role of DIII-IV linker in Ca 2+ -dependent regulation of coupled Na V 1.5 channels. The involvement of CaM and the details of Ca 2+ -dependent regulation of Na V 1.5's cooperative gating mechanism are yet to be determined. Na V β1 Regulates Na V 1.5 Gating Through CaM Interacting Domains
The interaction between monomeric Na V 1.5 during channel biogenesis is mediated by Na V β1 (Mercier et al., 2012) , but the involvement of Na V β1 in the gating of coupled channels or in Ca 2+ -dependent mechanisms have not been elucidated. The reported effects of Na V β1 on Na V 1.5 gating parameters in mammalian expression systems are conflicting, generally suggesting that the cellular environment is critical for channel function (Calhoun and Isom, 2014) . Similar to previous reports Wingo et al., 2004; Zhu et al., 2017) we showed that Na V β1 co-expression right-shifted Na V 1.5 WT SSI curve (Figure 4D, bottom) . Further, we showed that Na V β1-induced a right-shift in Na V 1.5 WT activation curve in the presence, but not in the absence, of Ca 2+ (Figure 4D, top) . This provides an indication for the role of Ca 2+ in Na V β1 regulation.
GFP-Na V 1.5 K1493del altered Na V 1.5 WT gating properties only when Na V β1 was not expressed, whereas in the presence of Na V β1, GFP-Na V 1.5 K1493del expression did not affect gating. Na V β1 was shown to modulate the voltage-sensor of Na V 1.5 domain IV (DIV, Figure 1C) , and is believed to localize in close proximity to DIII-IV linker Zhu et al., 2017) . Thus, we propose that Na V β1 is intricately involved in the Ca 2+ -dependent gating regulation, and can modify the contribution of DIII-IV linker to Na V 1.5 channels' cooperative-gating modulation.
Both effects of Na V β1 on Na V 1.5 WT were eliminated in Na V 1.5 A1924T * : the gating modulations and the loss of Na V 1.5 K1493del effect, indicating that A1924 residue may mediate Na V β1 regulation. Interestingly, structural dimers were found in the CT of Na V 1.5. In the dimer, position 1924 is located in the interface of Na V 1.5 CT dimer, and A1924T mutation was shown to attenuate these interactions (Gabelli et al., 2014) . In view of the structural and functional data, we suggest that cytosolic interaction between Na V β1 and the IQ domain(s) in Na V 1.5 cytosolic CT, including A1924 residue, are involved in the regulation of Na V 1.5-gate. Since both DIII-IV linker and A1924T are thought to be included in the CaM-Na V 1.5 interaction complex, we postulate that Na V β1 is part of a cytosolic CaM-interaction complex and a dynamic modulator of a complexed Ca 2+ -regulated gate that comprises DIII-IV linker and the CT of multiple Na V 1.5 channels.
The Effect of Na V 1.5 Mutants on the Clinical Properties
Compound heterozygosity in SCN5A was associated with increased arrhythmic expression compared to heterozygotes in the same family. The clinical phenotype included severe bradycardia and conduction disease, which represents a reduction in electric activity of both the sinus-atria and the conduction system. Among the two mutations that were detected in the proband, the most striking biophysical feature is the loss-of-function due to K1493del mutation, which would lead to a 50% reduction in I Na and haploinsufficiency. The changes in gating that arise from the second Na V 1.5 variant, A1924T * , are expected to have a relatively mild impact on cardiac rhythm but might have added to the pathological expression on the background of Na V 1.5 K1493del .
The physiological implication of Ca 2+ modulation of Na V 1.5 is heart-rate dependent. During low-to-normal heart rate, I Na transient of the cardiac action-potential precedes the Ca 2+ transient and senses low Ca 2+ levels. Repetitive and fast Ca 2+ transients, during tachycardia, are expected to reveal Ca 2+ -dependent conformational changes in protein complex formation that are limited by the association/dissociation rate, like Na V 1.5-CaM direct interaction, and other distal Ca 2+ -induced pathways. Na V 1.5 channels are physiologically modulated by Na V β1 in cardiac cells (Edokobi and Isom, 2018) . Interestingly, A1924T * mutant blunted Na V β1-induced gating modulation. Close to resting potential and in the absence of Ca 2+ , the availability of Na V 1.5 A1924T * + Na V β1 channels to open is two times lower than that of Na V 1.5 WT + Na V β1, which is expected to reduce the action-potential upstroke during low-to-normal heart rate ( Figure 4D) , and may explain the BrS phenotype reported in A1924T carriers (Rook et al., 1999) . The addition of Na V 1.5 K1493del on top of Na V 1.5 A1924T * + Na V β1 increased the number of Na V 1.5 channels available to open at rest (Figure 4F , right). This restoration of SSI properties may have moderated the development of BrS ECG pattern in the compound-heterozygote in our study, although a low penetration of A1924T phenotype cannot be ruled out.
In high Ca 2+ , the window current of Na V 1.5 A1924T * + Na V β1 is shifted to hyperpolarized voltages comparing to Na V 1.5 WT , resulting in increased Na V 1.5 excitability. We speculate that this property can facilitate conduction and increase the propensity for development of exercise-induced atrial flutter with rapid ventricular response, on the background of bradycardia and conduction disease, that was demonstrated in the compound heterozygote in this study (Figure 1A, right) .
It is noteworthy that certain loss-of-function mutations are expressed in BrS phenotype, e.g., A1924T, while others are associated with slow cardiac conduction and bradycardia, without BrS ECG pattern, e.g., K1493del [see also (Hu et al., 2010; Park et al., 2015) ]. Possibly, the impaired mechanism that results in a loss-of-function plays a critical role in the downstream expression of the syndrome.
Extrapolation of the biophysical properties of mutated channels to disease expression, in the presented proband, is limited since we cannot determine the relative expression of each allele in the compound heterozygote cardiac cells, and thus we cannot determine the relative functional contribution of each mutated channel. In addition, the role of the polymorphism V1251M was not studied. The use of induced pluripotent stem-cells derived cardiomyocytes (iPSC-CMs), originated from the proband's cells, would be an attractive approach to investigate how the composite of mutations with distinct biophysical properties results in the cardiac phenotype, in a complex molecular environment, and in dynamic (Ca 2+ ) cycles.
CONCLUSION
We show that K1493del mutation induces a complete loss-of-function of Na V 1.5 due to gating, rather than biogenesis, defect. The effect of K1493 deletion is independent of the electric charge in this position. K1493del is associated with impaired CaM-interaction and Ca 2+ -dependent modulation of sodium currents. Na V β1 gating regulation is Ca 2+ -dependent and involves the Na V 1.5 CT. These results highlight the role of Na V 1.5 DIII-IV linker in Na V 1.5-CaM-interaction and support a coupling between Na V 1.5 channels that is implicated in a Ca 2+ -dependent gating mechanism.
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